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Abstract
Background: Pain is a common symptom, often associated with neurological and musculoskeletal conditions, and
experienced especially by females and by older people. The aims of this study are to evaluate the temporal
variations of pain rates among general populations for the period 1991–2015 and to project 10-year pain rates.
Methods: We used the harmonized dataset of ATHLOS project, which included 660,028 valid observations in the
period 1990–2015 and we applied Bayesian age–period–cohort modeling to perform projections up to 2025. The
harmonized Pain variable covers the content “self-reported pain experienced at the time of the interview”, with a
dichotomous (yes or no) modality.
Results: Pain rates were higher among females, older subjects, in recent periods, and among observations referred
to cohorts of subjects born between the 20s and the 60s. The 10-year projections indicate a noteworthy increase in
pain rates in both genders and particularly among subjects aged 66 or over, for whom a 10–20% increase in pain
rate is foreseen; among females only, a 10–15% increase in pain rates is foreseen for those aged 36–50.
Conclusions: Projected increase in pain rates will require specific interventions by health and welfare systems, as
pain is responsible for limited quality of subjective well-being, reduced employment rates and hampered work
performance. Worksite and lifestyle interventions will therefore be needed to limit the impact of projected higher
pain rates.
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Introduction
Pain is defined as “a distressing experience associated
with actual or potential tissue damage with sensory,
emotional, cognitive, and social components” [1] and is
one the most common symptoms. It can be associated
with many conditions, including some highly prevalent
and disabling ones, such as headaches, musculoskeletal
diseases or injuries, but also to sequelae of other disor-
ders, such as diabetes [2]. These conditions often have
long-lasting duration: they begin in adulthood, endure
for several years and often worsen, and are associated
with disability [3–5]. Pain rates are expected to rise due
to the increased prevalence of musculoskeletal and
neurological diseases, increased life expectancy and in-
creased proportion of elderly in societies [6].
The results of epidemiological studies show that the
prevalence of pain-associated conditions is between 10%
and 40% approximately [7–17]: the only exception to
this is for the one-year prevalence of tension-type head-
ache, which peaked up to 60% [13–15]. Literature also
show that pain is more frequently experienced by fe-
males and by older people, which is consistent with the
epidemiological presentation of the main drivers of pain,
i.e. headache and musculoskeletal disorders. Based on
these figures, it could be hypothesized that most of the
general population would report pain as a daily or near-
daily problem. However, reliable information on the
presence and time trend of pain in the general popula-
tion, irrespective of underlying health conditions, is lim-
ited to few studies. A recent one, which analyzed 18-year
trends in the overall rates of noncancer pain prevalence
in the U.S., showed that the proportion of adults report-
ing pain due to painful health conditions increased from
32.9% to 41.0% between 1997 and 98 and 2013–14 [18].
Understanding such a trend, as well as the projections
towards future periods, is of relevance for the manage-
ment of pain as a symptom, particularly for the risk of
overuse of medications such as opioids [18–20]. In
addition to this, issues connected to worse health out-
come, e.g. higher disability, reduced employment rates
and loss of productivity are also of relevance [21–28].
This is, in turn, an important determinant of economic
burden, which is high because of both per-case cost and
general prevalence of pain-related conditions [29–33].
However, while higher pain rates among females and
among older subjects, and occasionally differences by
period have been shown, with higher pain rates in recent
periods [6, 18], information on pain rates by cohort is
basically lacking. The integration of gender, age, period
and cohort data is of core importance to produce projec-
tions on pain rates in the general population.
The aims of this study are to evaluate the temporal
variations of pain rates among the general populations
for the period 1991–2015 and to predict future rates up
to 2025. These variations were analyzed by gender con-
sidering age, periods (year of survey) and cohorts (birth
year), as derived by the ATHLOS project (Ageing Tra-
jectories of Health – Longitudinal Opportunities and
Synergies) harmonized dataset, which includes data col-
lected in different studies carried out in the five
continents.
Materials and methods
ATHLOS project and the harmonized dataset
ATHLOS project was funded by the European Union’s
Horizon 2020 Research and Innovation Program, and it
aims to achieve a better understanding of the impact of
ageing on health. To achieve this result, a new cohort
has been composed from harmonized datasets of exist-
ing international longitudinal cohorts related to health
and ageing (see: https://github.com/athlosproject/athlos-
project.github.io). The harmonized dataset includes re-
cords of participants from 17 different studies and is
fully described elsewhere [34]: most of these studies
were run between 2000 and 2010 and have at least two
waves, but there are both older and more recent ones, as
well as studies with one wave only. The harmonized
ATHLOS mega-dataset comprises approximately 411,
000 respondents. Most of the studies whose data are in-
cluded in ATHLOS dataset were from high-income
countries and upper-middle-income countries: the only
exceptions are India and Ghana.
ATHLOS harmonized dataset is composed of a wide
range of variables covering a variety of health conditions,
sociodemographic variables, personal functioning and
contextual factors, which are usually assessed in popula-
tion studies. The ATHLOS dataset variables were classi-
fied in the following domains: sociodemographic and
economic characteristics, lifestyle and health behaviors,
health status and functional limitations, diseases, living
status, physical measures, psychological measures, la-
boratory measures, social environment and life events,
and administrative information [34].
Pain is included within health status and functional
limitations and was measured in 14 out of the 17 studies,
with different approaches (please refer to supplementary
materials for information on the distribution of pain
variable across studies and countries). Some studies, e.g.
the Collaborative Research on Ageing in Europe [35]
and the China Health and Retirement Longitudinal
Study [36], addressed it in terms of pain severity (i.e.
None, Mild, Moderate, Severe, Extreme or other similar
formats). Other studies, e.g. the Australian Longitudinal
Study of Aging [37] and the Survey of Health, Ageing
and Retirement in Europe [38], dichotomously addressed
the presence of pain (i.e. yes or no), sometimes address-
ing the idea that pain is “often experienced”, such as in
the Irish Longitudinal Study of Ageing [39]. The
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harmonization procedure is aimed to generate inferen-
tially equivalent content across studies so to make the
content of variables collected in different studies uni-
form. In the case of pain variable, the content was “self-
reported pain experienced at the time of the interview”,
and the variable modality was dichotomous.
Age period cohort analysis
Age period cohort (APC) models are commonly used to
analyze and project rates [40, 41]. APC models account
for these processes on three time scales: age, year of sur-
vey (period) and year of birth (cohort). The period and
cohort effects are both surrogates for exposure to exter-
nal factors. Period effects include environmental and
diagnostic factors. For example, the introduction of a
new diagnostic procedure may lead to a jump in disease
incidence across all age groups. Cohort effects represent
risk factors that change over time and may have a de-
layed effect on disease outcomes. For example, lifestyle
factors, such as alcohol and tobacco consumption, can
manifest themselves as cohort effects [41].
Data were organized by five-year periods from 1991 to
2015, five-year age-groups from the group 31–35 to the
96–100 one and stratified by gender. In a preliminary
analysis, age-specific trend rates by gender were com-
puted. Trend rates vary between 0 and 1, with higher
values indicating higher proportion of pain reporting in
specific subgroups and observations, i.e. among males
and females, by age, cohort and periods. Later, APC
models were fitted to analyze the joint effects of the age,
period, and cohort, expressed in Rate Ratio (RR) terms.
RR is a relative measure that allows to identify potential
protective (if RR < 1) and risk factors (if RR > 1), in this
case related to particular ages, periods or cohorts. Pain
counts yijk in age group i at time point j in k
th cohort
can be assumed to be Poisson distributed, i.e.,
yijk ¼ Po nijkλijk
 
;where i ¼ 1;…; I; j ¼ 1;…; J; k ¼ 1;…;K;
with mean nijkλijk, where nijk denotes the corresponding
subjects at risk. In our application, the age index i run
from 1 to I = 14 (both in males and females), while the
period index j run from 1 to J = 5. Concerning the co-
hort index k, it depended on the age group and period
index, but also on their intervals width [42, 43] and it
was defined as M × (I − i) + j, where M indicated the ratio
between the width in years of the age group and the
period intervals [44]. In our application M was equal to [5
years] / [5 years] = 1, and the cohort index k, following the
previous formula where the age groups were fourteen and
the periods are five, generated K = 1 × (14–1) + 5 = 18 co-
horts, i.e., the cohort index run from 1 to K = 18, but only
9 not overlapping (i.e., 1891–1900, 1901–1910,…,1971–
1980). Given that, the model was specified as
Log λijk
  ¼ μijk ¼ μþ αi þ β j þ γk
Here μ represented the general level (intercept), and
αi, βj, γk denoted age, period, and cohort random effects
(to be estimated), respectively [45].
A fully Bayesian approach based on Integrated Nested
Laplace Approximations (INLA) was considered for
model fitting and inference [46]. A Bayesian APC model
provides a more robust methodology compared to a log-
linear model, particularly for the prediction of future oc-
currence [47–49]. Indeed, in our case, Bayesian age–
period–cohort modeling was also used to perform pro-
jections, and relative credible intervals (CI), of the pain
symptom rates in the time interval 2015–2025, extrapo-
lating the trend of rate from 1990 to 2015 and consider-
ing the subjects at risk relative to the last period 2011–
2015. For each projection, different degrees of CI were
reported, the closer to the predicted mean being 10% CI
and the largest being 95% CI.
The model had some a priori assumptions: (i) log-RR
for each effect summed to zero over the observed inter-
val; (ii) the expected effects were hypothesized to be
constant, so that both the large and the small deviations
from a constant rate are detected. The Bayesian APC
model also considered hyper-parameters of random walk
type of first (RW1) and second order (RW2) [50] on
which log-gamma prior distributions were elicited. We
intentionally used highly non-informative log-gamma
prior distributions (with parameters equal to 1 and
0.00005) in order to endorse and make more credibility
to harmonized ATHLOS dataset and avoid the impos-
ition of assumptions for which no a priori knowledge
was available. A prior distribution on an overdispersion
parameter was also elicited by an independent log-
gamma with parameters equal to 1 and 0.005.
Parameter estimates in terms of mean and median
were obtained. Finally, to select the best model among
the different proposals, the Deviance Information Criter-
ion (DIC, lower was better) [51] were computed. In par-
ticular, different specification as age period and age
cohort models, and different combinations of priors of
RW1 and RW2 [50] were probed by considering the ran-
dom effects of age, period and cohort. In case RW1 and
RW2 priors provided very similar DICs, we decided to
select the complete model with RW2 priors because is a
standard choice as natural target for smoothing [52, 53].
The technique was implemented in the software R v
3.5.2 [54] through the packages R-INLA (www.r-inla.
org) [55–57] and Bayesian APC [50] for the projections.
Results
In total 660,028 valid observations were used, of whom
293,484 reported some degree of pain, the rate being
44.5% (see Table 1): the rate of pain was higher among
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observations referred to females than to males. As
shown in Table 2, the average age of participants at the
time of observation was comprised between 64 and 65
years across all periods, with the exception of the 1991–
1995 one, where the average age was approximately 5
years below that of the other periods. Supplementary
Tables S1-S4 report distribution of all observations and
of observations with pain by period and by 5-years age
groups; supplementary Tables S5-S8 report the same in-
formation not aggregated by 5-years periods.
Figure 1 reports the observed pain rates by age, period
and cohort for males and females. Among males rates by
age varied approximately between 0.3 and 0.4, increasing
with age and remaining basically stable after 80 years of
age; among females, rates by age varied approximately
between 0.4 and 0.54, peaking at the age class 81–85
and declining thereafter. With regard to rates by periods,
a consistent increase was observed in both genders:
among males it varied between 0.2 and 0.4, among fe-
males between 0.3 and 0.5. Regarding rates by cohort, it
has parabolic shapes in both genders: among males the
peak was around 0.4 for the cohort born in 1941–1950,
among females it was around 0.5 for the cohorts born
between 1921 and 1950.
Age-specific rates by gender and per period are
shown in Fig. 2. Rates were higher among females
and, in both genders, were higher among older sub-
jects. A trend related to the period was observed, in
both genders and across all age groups, with partici-
pants recruited in more recent periods experiencing
pain with a higher frequency. An exception to this is
observed for participants aged below 50 for whom, in
the period 2010–2015, a decline in trend was ob-
served in both genders.
Figure 3 shows the results of the APC models. The ef-
fect of age was different among males and females: in
fact, while a consistent increasing trend was observed in
females, with age becoming a risk factor for pain in the
seventh decade of life, the age effect in males decreased
from the first age group up to the 50–55 group and then
it increased, becoming a risk factor in the eighth decade
of life. The period effect was constantly growing in both
males and females and it became a risk factor for pain
from the period 2006–2010 onwards. The cohort effect
had a parabolic shape: being born between the 20s and
the 60s was a risk factor for pain in both genders. The
selected models for both males (DIC = 650.6) and fe-
males (DIC = 723.8) involved the complete age period
cohort models and the choice of RW2 priors (see sup-
plementary Table S9). It is worth to point out that the
estimated decreasing trend for the youngest age groups
in males could be due to the small number of periods in
relation to the age groups. In order to account for that,
we have also performed a sensitivity analysis where the
periods were non-aggregated (data are included in sup-
plemental materials, Tables S5-S8). The results of this
last analysis were very similar to that of those carried
out with aggregated data: only for the period effects dif-
ferences on the trends that presented a more irregular
increase were detected (see Fig. S1). Moreover, because
of data sparsity, sensitivity analysis could not produce
projection as estimates intervals would have been too
wide and unstable.
Figures 4 and 5 show observed and predicted rates for
all age groups and for males and females, respectively.
For both males and females, the projection is indica-
tive of an increase in pain rates between 2015 and
2025, and such an increase was wider among older
subjects. Among males, the projected increase over
the decade was higher than 10% in all age groups
from the 66–70 one, and get close to 20% for the age
groups 91–95 and 96–100 (Fig. 4m-n). The same ap-
plies to females, for whom however the projection
over the decade was higher than 20% in the oldest
group (Fig. 5n). Moreover, an increase comprised be-
tween 10% and 15% over the decade was also ob-
served among females for the age groups comprised
between 36 and 50 years (Fig. 5b-d).
Table 1 Presence of pain in the general population included in
ATHLOS harmonized dataset by age class
Age class Males Females Total
31–50 Observations 18,287 37,510 55,797
Cases with pain 6085 14,886 20,971
% cases with pain 33.3% 39.7% 37.6%
51–70 Observations 182,094 223,289 405,383
Cases with pain 70,425 106,939 177,364
% cases with pain 38.7% 47.9% 43.8%
> 70 Observations 83,389 115,459 198,848
Cases with pain 34,331 60,818 95,149
% cases with pain 41.2% 52.7% 47.8%
Total Observations 283,770 376,258 660,028
Cases with pain 110,841 182,643 293,484
% cases with pain 39.1% 48.5% 44.5%
Table 2 Age by period
Period Males Females Total
1991–1995 60.6 ± 8.7 58.5 ± 10.1 59.4 ± 9.6
1996–2000 64.8 ± 11.0 64.8 ± 12.5 64.8 ± 11.9
2001–2005 64.6 ± 10.2 64.1 ± 11.5 64.3 ± 10.9
2006–2010 65.1 ± 10.9 65.0 ± 11.9 65.1 ± 11.5
2011–2015 64.9 ± 10. 7 64.8 ± 11.5 64.8 ± 11.2
Total 64. 7 ± 10.6 64.4 ± 11.7 64.5 ± 11.3
Note. Data are expressed in years as mean ± standard deviations
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Discussion
The results of this study confirm part of the finding of
previous literature, namely higher rates of pain among
females and among older subjects, and reinforce the few
available data on period analysis by showing higher pain
rates in more recent periods, with specific reference to
the observations referred to older subjects. In addition
to this, our results show that pain rates were higher
among the observations referred to cohorts of subjects
born between the 20s and the 60s (i.e. between 1921 and
1970). Finally, the most innovative aspect of our work
lies in the 10-year projection for pain rates, which indi-
cate a noteworthy increase in pain rates across all age
groups and in both genders. Among males aged 66 and
over, the increase is projected to be by 10–20% over the
decade, and the same is for females: in addition to this,
however, also females aged 36–50 will likely face a 10–
15% increase in pain rates.
Taken as a whole, our results tell the story of an ex-
pansion of pain-related morbidity, irrespective of its aeti-
ology. Chronic pain prevalence has been occasionally
addressed, but available reports show that it is increasing
with age and through the years as an effect of population
ageing [58, 59]. In addition to the known effect of age,
some reports have also shown that people enrolled in re-
cent years in population studies tend to report higher
pain rates, i.e. an effect of age [6, 18] which may underlie
differences in pain reporting, that might be due to cul-
tural or biological issues. Our data do not enable to
make hypotheses on what is causing such a period effect,
but it has to be acknowledged that the prevalence of
some conditions is rising worldwide. Examples of this in-
clude diabetic neuropathy, which affects up to 50% of
patients with diabetes [60] and is expected to increase in
consideration of the rising prevalence of diabetes world-
wide [61, 62], and musculoskeletal conditions, which are
among the main pain drivers, and represent approxi-
mately 19% of non-communicable diseases in terms of
prevalence and 20% in terms of disability [2].
In consideration of the higher impact of such condi-
tions among older subjects, and in consideration of glo-
bal population ageing, actions aimed to prevent and
control pain are and will be more and more needed. It is
interesting to notice the increase in pain rates which is
Fig. 1 Observed rate of pain in males and females by age, period and cohort. a: pain rates by age. b: pain rates by period. c: pain rate by cohort.
Note. The dark central line indicates rate = 0.5
Fig. 2 Observed pain rate in males and females in the ATHLOS dataset. a: age-specific pain rates by age for males. b: age-specific pain rates by
age for females
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specific for females aged 36–50. This age group is at
higher risk of having migraine or tension-type headache
[3, 63–66]. It has to be noted that, as shown by GBD
data [3], the decrease in prevalence of headache disor-
ders begins after the age of 30, but the decline is particu-
larly pronounced after the age of 50, particularly among
women; this may be the reason for the differential in-
crease by gender in the 36–50 age group. In addition to
this, there are biological differences that make women to
be exposed to specific pain, such as cyclic menstrual
pain or menstrual migraine, which affects 22% to 62% of
female migraineurs [67, 68]. Such an increase in pain
rates will also be accompanied by an increase in the
amount of the portion of population in that age group
(third to fifth decade of life) in high and upper-middle
income countries. In fact, in high-income countries, the
median age between 1990 and 2015, moved from 33.4 to
40.4, and is projected to span between 41.5 and 43.5 in
2020–2030; in upper-middle income countries, the me-
dian age between 1990 and 2015, moved from 24.5 to
33.9, and is projected to span between 35.6 and 39.9 in
2020–2030 [69]. Therefore, it can be hypothesized that
headache disorders will contribute more and more to
the overall burden of pain in general populations. In
addition to this, headache disorders and back pain,
which are among the most prevalent and disabling con-
ditions [2], show considerable rates of comorbidity, with
odds of association comprised between 1.55 and 8.00
[70].
It is reasonable to hypothesize that in the older age
groups, the difference in the increase of pain might be
associated to the higher impact of some skeletal condi-
tions, such as osteoporosis, and to the associated higher
fracture rates. In fact, osteoporosis is approximately
three-fold more prevalent in women than in men [71],
and women older than 60 years have a 44% lifetime risk
of fractures, compared to 25% among men of the same
age [72].
Increasing pain rates will most likely be associated
with increased healthcare utilization and consumption of
different kinds of analgesics [73–75], and in particularly
opioids, which however may in turn produce negative
Fig. 3 Estimated effects of age, period and cohort in rate ratio terms by gender. a: estimated effect of age. b: estimated effect of period. c:
estimated effect of cohort. Note. The dark central line indicates RR = 1
Fig. 4 Pain rates and 10-years pain rate projection per age group in males. a: pain rate projection, males, age 31–35. b: pain rate projection,
males, age 36–40. c: pain rate projection, males, age 41–45. d: pain rate projection, males, age 46–50. e: pain rate projection, males, age 51–55. f:
pain rate projection, males, age 56–60. g: pain rate projection, males, age 61–65. h: pain rate projection, males, age 66–70. i: pain rate projection,
males, age 71–75. j: pain rate projection, males, age 76–80. k: pain rate projection, males, age 81–85. l: pain rate projection, males, age 86–90. m:
pain rate projection, males, age 91–95. n: pain rate projection, males, age 96–100. Note. The predictive mean is shown as solid line. The different
shadings indicate pointwise credible intervals. The central interval represents 10% CI, and the largest interval 95% CI. Observed rates are shown as
a filled circle. The vertical dashed line indicates where prediction started
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health outcomes and a further increase of healthcare use
[76, 77]. In addition to this, pain is associated with re-
duced work productivity and sick leave [22, 26, 27, 78–
81], early retirement and reduced employment rates [21,
25, 28, 82, 83]. The old-age dependency ratio, i.e. the ra-
tio of the population aged 65 years or over to the popu-
lation aged 15–64 -- referred to as the number of
dependants per 100 persons of working age -- has been
constantly increasing and is projected to further increase
in both high-income and upper-middle-income coun-
tries. In high-income countries the dependency ratio in-
creased from 18.3 to 25.7 between 1990 and 2015, and is
projected to span between 25.8 and 36.3 between 2020
and 2030; in upper-middle-income countries the in-
crease was from 8.1 to 10.5 between 1990 and 2015, and
the rate will span between 12.3 and 16.2 between 2020
and 2030 [69]. Thus, our projections are not only indica-
tive of an increased risk of future worse health status,
but also of higher healthcare expenditure and overall fi-
nancial burden which the health and welfare systems of
high and upper-middle income countries, i.e. countries
from which most of observations included in ATHLOS
dataset were drawn [34], likely will struggle to bear.
Interventions are therefore needed to prevent pain and
limit the impact of projected higher pain rates, which
should include worksite interventions [84–89], lifestyle in-
terventions and control over prescribed drugs [89–92].
Worksite intervention should be aimed to limit work ces-
sation as well as enhance work productivity, and should
ideally to be tailored to the features of each individual.
Practically, these interventions can be tailored to the fea-
tures of specific disorders as well, and may thus involve
specific actions. A synthesis of the most effective strategies
included among available literature [84–92] is beyond the
aims of this study, but some general considerations can be
made. Evidence exist that effective interventions act upon
different levels, i.e. both patients and the workplaces, and
involve several stakeholders, including treating pain spe-
cialists, occupational physicians and employers, and the
most commonly reported strategies include appropriate
pharmacotherapy, provision of ergonomic furniture, pa-
tients’ education on pain management, relaxation/posture
exercises. Lifestyle interventions are aimed to reduce fac-
tors contributing to pain exacerbation and pain triggers,
and most of them target diet and physical activity, as well
as appropriate drug prescription and adherence to treat-
ment. Finally, preliminary research evidence is available
on the effectiveness of behavioral treatments, alone or as
add-on to medical ones, for chronic pain control [93–95].
More research is needed in this field, that seems however
promising and could provide a substantial contribution to
control pain experience and reduce the consumption of
medications.
Some limitations have to be acknowledged. The age
period cohort models are commonly used to analyse and
project mortality or morbidity rates from health registers
to routinely collect demographic rates. However, the
data herein reported do not derive from registries but
from cross-sectional and longitudinal surveys, harmo-
nized in the ATHLOS dataset. This entails that the
population is not the same across periods, and therefore
the sample sizes were different. Moreover, our analysis
did not consider population dynamics either. In addition
to this, it has to be remembered that our analysis is
based on a harmonized dataset, whose core definition of
pain variable is “self-reported pain experienced at the
time of the interview”, with a dichotomous output. This
creates an important limitation, namely the fact that this
Fig. 5 Pain rates and 10-years pain rate projection per age group in females. a: pain rate projection, females, age 31–35. b: pain rate projection,
females, age 36–40. c: pain rate projection, females, age 41–45. d: pain rate projection, females, age 46–50. e: pain rate projection, females, age
51–55. f: pain rate projection, females, age 56–60. g: pain rate projection, females, age 61–65. h: pain rate projection, females, age 66–70. i: pain
rate projection, females, age 71–75. j: pain rate projection, females, age 76–80. k: pain rate projection, females, age 81–85. l: pain rate projection,
females, age 86–90. m: pain rate projection, females, age 91–95. n: pain rate projection, females, age 96–100. Note. The predictive mean is shown
as solid line. The different shadings indicate pointwise credible intervals. The central interval represents 10% CI, and the largest interval 95% CI.
Observed rates are shown as a filled circle. The vertical dashed line indicates where prediction started
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variable does not account for two issues of relevance in
pain experience. The first is the severity and impact of
pain, which spans between mild and disabling; the sec-
ond is the frequency with which pain is experienced,
which might be daily or near-daily, such as pain due to
musculoskeletal conditions, episodic with variable fre-
quency, such as in the case of headache disorders, or oc-
casional. Finally, we interpreted the results of pain
trends in light of the trends that can be reasonably ex-
pected for musculoskeletal and headache disorders in
reason of their prevalence in the general population.
However, none of the original pain-related variables in-
cluded specification of pain in terms of aetiology or
location.
Conclusion
In conclusion, we reported data on the temporal varia-
tions of pain rates among the general population for the
period 1991–2015 and predicted 10-years future rates.
Our results are based on a very large international data-
set, which included data from populations from the five
continents. Results show that pain rates were higher
among females and among older subjects, and that rates
were also higher among the respondents enrolled in
more recent periods. Finally we showed that the trends
of pain are increasing, in particular among females and
among older subjects, for whom a 10–20% increase is
projected over the 10-year period.
Pain is strongly associated with reduced employment
rates and hampered work performance which, in consider-
ation of population ageing and projected increase of de-
pendency ratio of older people on people of working age,
will require specific actions by health and welfare systems.
Worksite and lifestyle interventions will be needed to limit
the impact of projected higher pain rates.
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